Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals

    Published: May 22, 2023 | Price: $5,000.00 – $10,000.00

    This report, Kalorama's Cell and Gene Deals and Market Analysis, tracks the dealmaking and market opportunity for cell and gene therapy companies.  A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. Kalorama's latest report finds that the volume of deals between companies and other funding entities involving CGT is up, and companies have continued to receive large amounts of investment despite a decline from 2021 levels of investment. Kalorama's CGT deals...
    The Market for Single Cell Analysis in Genomics: Next-Generation Sequencing and Other Technology, 2023-2027

    Published: April 3, 2023 | Price: $5,000.00 – $10,000.00

    The Market for Single Cell Analysis in Genomics: Next-Generation Sequencing and Other Technology, 2023-2027  focuses on the market for single cell genomics products. Analyzed are the hardware, service of the hardware, software, and consumables included for the sequencing step and other types of downstream analysis. Single cell RNA-seq enables new types of analyses, for instance: understanding tumour heterogeneity and clonal evolution (including studying lineage analysis, cancer stem cells, and drug-resistant and metastatic clones), understanding complex tissues (e.g. neural tissues), high resolution...
    The Market for RNA Sequencing, 2nd Edition

    Published: September 7, 2022 | Price: $0.00 – $9,000.00

    The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas.  In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it.  Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...
    Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022

    Published: August 2, 2022 | Price: $6,000.00 – $12,000.00

    This report, Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022, describes and discusses the global contract manufacturing markets, specifically focusing on the production of biotech (large molecule) products including extensive coverage of the biotechnology segment of the global BCMO industry. Sales estimates are provided by segment and region, expressed in current dollars. Estimates are provided for the historic 2016 to 2021 period and forecasts are provided through 2026. Further, this report examines third party manufacturing of potential and commercialized prescription drug...
    Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027

    Published: May 5, 2022 | Price: $6,000.00 – $12,000.00

    Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027 focuses on the market for single cell genomics products -- the hardware, service of the hardware, software, and consumables including for the sequencing step and other types of downstream analysis.  It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market.  The competitive situation, deals, and products are covered in respective chapters.  Historical data for...
    Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments

    Published: February 16, 2022 | Price: $5,000.00 – $10,000.00

    Cell and Gene Therapy Funding Reached $70 Billion in 2021. How Can You Keep Up with the Activity in this Industry? A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently.  There are now many approved therapies with proven track records.  As the tools have lowered the barriers to entry for the industry, over a thousand companies have been created or become involved.  Fortunately, Kalorama Information has been tracking every significant development in...